Search - tctmd.com

Displaying 861 - 880 of 1526

Sort: Relevancy | Date

Presentation JIM 2016

Transcatheter Tricuspid Valve Repair

Presenter: Joachim Schofer

February 10, 2016

Presentation JIM 2016

State of the art of TMVR

Presenter: Ottavio Alfieri

February 10, 2016

Presentation JIM 2016

How we manage patient with MR in San Raffaele

Presenter: Antonio Colombo

February 10, 2016

Presentation JIM 2016

Direct Flow Medical: Latest Data on a Unique Structural Heart Technology

Presenter: Azeem Latib

February 10, 2016

Presentation Scripps 2016

Valve-in-Valve Therapy for Failed Surgical Bioprosthetic Valves: Clinical Results and Procedural Approach

Presenter: Susheel K. Kodali

February 03, 2016

Presentation Scripps 2016

The “Forgotten Valve”: Current and Emerging Options for Catheter Based Treatment of Tricuspid Regurgitation

Presenter: Rebecca T. Hahn

February 03, 2016

Presentation Scripps 2016

PVL Closure: Keys to Success

Presenter: Paul Sorajja

February 03, 2016

Presentation Scripps 2016

Intraprocedural TEE Guidance of Transcatheter Mitral Valve Repair

Presenter: William J. Stewart

February 03, 2016

Presentation Scripps 2016

Current Dataset for Transcatheter Mitral Repair and Its Impact on Patient Selection

Presenter: Jason H. Rogers

February 03, 2016

Presentation Scripps 2016

New Transcatheter Therapies: What Is Next On The Horizon?

Presenter: Susheel K. Kodali

February 02, 2016

Presentation Scripps 2016

Complex Case Studies: Everything but the Kitchen Sink

Presenter: Patricia A. Keegan

February 02, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

Presentation

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Presenter: Ted Feldman

December 21, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Daily News

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Michael O'Riordan

December 06, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

Presentation

First-in-Man Experience With a Novel Transcatheter Repair System for Severe Tricuspid Regurgitation (TR)

Presenter: F. Campelo-Parada

December 03, 2015

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

November 22, 2015

Advertisement

Transcatheter Tricuspid Valve Repair

State of the art of TMVR

How we manage patient with MR in San Raffaele

Direct Flow Medical: Latest Data on a Unique Structural Heart Technology

Valve-in-Valve Therapy for Failed Surgical Bioprosthetic Valves: Clinical Results and Procedural Approach

The “Forgotten Valve”: Current and Emerging Options for Catheter Based Treatment of Tricuspid Regurgitation

PVL Closure: Keys to Success

Intraprocedural TEE Guidance of Transcatheter Mitral Valve Repair

Current Dataset for Transcatheter Mitral Repair and Its Impact on Patient Selection

New Transcatheter Therapies: What Is Next On The Horizon?

Complex Case Studies: Everything but the Kitchen Sink

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

First-in-Man Experience With a Novel Transcatheter Repair System for Severe Tricuspid Regurgitation (TR)

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content